These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2446076)

  • 21. 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency.
    Wenting GJ; Woittiez AJ; Man in't Veld AJ; Schalekamp MA
    Hypertension; 1984; 6(1):100-9. PubMed ID: 6319278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of renal vasoconstrictor effect of NG-nitro-L-arginine in rabbit by angiotensin II and alpha-1 adrenergic receptor blockade.
    Hajj-Ali AF; Reilly TM; Wong PC
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1152-7. PubMed ID: 7932165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
    Chaouloff F; Jeanrenaud B
    J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between ketanserin and LY 53857 on vascular and cardiac 5-HT2 and alpha 1-adrenergic receptors in the pithed rat.
    Dabiré H; Chaouche-Teyara K; Cherqui C; Fournier B; Schmitt H
    Arch Int Pharmacodyn Ther; 1990; 306():57-64. PubMed ID: 1981667
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular profile and hypotensive mechanism of ketanserin in the rabbit.
    Bolt GR; Saxena PR
    Hypertension; 1985; 7(4):499-506. PubMed ID: 2861161
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of central alpha1- and alpha2-adrenoceptors on cardiovascular responses to moxonidine.
    Moreira TS; Takakura AC; Menani JV; Colombari E
    Eur J Pharmacol; 2007 Jun; 563(1-3):164-71. PubMed ID: 17382316
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for an alpha-1 receptor-mediated central sympathoinhibitory action of ketanserin.
    McCall RB; Schuette MR
    J Pharmacol Exp Ther; 1984 Mar; 228(3):704-10. PubMed ID: 6323678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ketanserin: a possible tool for studying the role of serotonin in hypertension.
    Woittiez AJ; Wenting GJ; Man in't Veld AJ; Boomsma F; Schalekamp MA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S130-6. PubMed ID: 2412035
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of the central sympathoinhibitory action of ketanserin.
    McCall RB; Harris LT
    J Pharmacol Exp Ther; 1987 May; 241(2):736-40. PubMed ID: 3572820
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal hemodynamic effects of ketanserin therapy in essential hypertension.
    Ram CV; Gonzalez DG; Kaplan NM; Ralakis JM; Henderson JD; Lugo CE; Zachariah N
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S78-80. PubMed ID: 2446078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antihypertensive properties of ketanserin (R 41 468).
    Vanhoutte PM; Van Nueten JM; Symoens J; Janssen PA
    Fed Proc; 1983 Feb; 42(2):182-5. PubMed ID: 6295821
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of ketanserin on peripheral vascular pressor mechanisms in essential hypertension.
    Elliott HL; Donnelly R; Reid JL
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S62-6. PubMed ID: 2459518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local hemodynamic effects of serotonin and ketanserin in healthy subjects: studies in the forearm.
    Blauw GJ; van Brummelen P; Bruning T; van Zwieten PA
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S41-3. PubMed ID: 2459513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Central hypotensive activity of ketanserin in cats.
    van Zwieten PA; Mathy MJ; Boddeke HW; Doods HN
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S54-8. PubMed ID: 2446072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of alpha adrenoceptor blockade on renal nerve stimulation-induced norepinephrine release and vasoconstriction in the dog kidney.
    Hisa H; Araki S; Tomura Y; Hayashi Y; Satoh S
    J Pharmacol Exp Ther; 1989 Feb; 248(2):752-7. PubMed ID: 2537415
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are there interactions between S2-serotonergic and alpha 1-adrenergic receptors in isolated canine arteries?
    Lüscher TF; Vanhoutte PM
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S16-21. PubMed ID: 2459508
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peripheral and central cardiovascular effects of ketanserin in conscious normotensive rats.
    Davy M; Midol-Monnet M; Heimburger M; Beslot F; Cohen Y
    Arch Int Pharmacodyn Ther; 1987 Dec; 290(2):193-206. PubMed ID: 3128194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade.
    Constantine JW; Lebel W; Weeks R
    J Cardiovasc Pharmacol; 1984; 6(1):142-50. PubMed ID: 6199597
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A comparative study of the effects of some 5-HT1A receptor agonists on the blood pressure of pithed rats.
    Castillo C; Bobadilla RA; Ibarra M; Castillo EF; Hong E
    Arch Med Res; 1995; 26(3):251-5. PubMed ID: 8580676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationships between pharmacokinetics and blockade of agonist-induced prostatic intraurethral pressure and mean arterial pressure in the conscious dog after single and repeated daily oral administration of terazosin.
    Witte DG; Brune ME; Katwala SP; Milicic I; Kerwin JF; Hancock AA
    J Pharmacol Exp Ther; 1997 Aug; 282(2):891-8. PubMed ID: 9262356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.